Literature DB >> 4942646

The assay of chlorpromazine and metabolites in blood, urine, and other tissues.

E Usdin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4942646     DOI: 10.3109/10408367109151312

Source DB:  PubMed          Journal:  CRC Crit Rev Clin Lab Sci        ISSN: 0590-8191


× No keyword cloud information.
  7 in total

Review 1.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 2.  Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.

Authors:  D J Boullin; H F Woods; R P Grimes; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

4.  Reduced steady-state plasma concentrations of chlorpromazine and indomethacin in patients receiving cimetidine.

Authors:  C A Howes; T Pullar; I Sourindhrin; P C Mistra; H Capel; D H Lawson; W J Tilstone
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Biotransformation of chlorpromazine and methdilazine by Cunninghamella elegans.

Authors:  D Zhang; J P Freeman; J B Sutherland; A E Walker; Y Yang; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

6.  Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites.

Authors:  D J Boullin; D G Grahame-Smith; R P Grimes; H F Woods
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

Review 7.  Schizophrenia: synthetic strategies and recent advances in drug design.

Authors:  Maria Azmanova; Anaïs Pitto-Barry; Nicolas P E Barry
Journal:  Medchemcomm       Date:  2018-03-16       Impact factor: 3.597

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.